Regenerated endothelium and its senescent response to aggregating platelets

Circulation Journal

Volumn 80, Issue 4, 2016, Pages 783-790

  Vanhoutte, Paul M ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

G proteins; Nitric oxide; Platelets; Regenerated endothelium; Serotonin

Indexed keywords

ACETYLCHOLINE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; APOCYNIN; BETA GALACTOSIDASE; BRADYKININ; CALCIUM IONOPHORE; COD LIVER OIL; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ERGOMETRINE; FATTY ACID BINDING PROTEIN 4; GUANINE NUCLEOTIDE BINDING PROTEIN; LOW DENSITY LIPOPROTEIN; MATRILYSIN; NITRIC OXIDE; NITROPRUSSIDE SODIUM; OXIDIZED LOW DENSITY LIPOPROTEIN; PERTUSSIS TOXIN; PROSTACYCLIN; PROTEINASE ACTIVATED RECEPTOR; PURINERGIC P2Y RECEPTOR; SEROTONIN; THROMBIN; THROMBOXANE A2; NOS3 PROTEIN, HUMAN;

ANGIOPLASTY; ATHEROSCLEROSIS; BALLOON CATHETER; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HEART TRANSPLANTATION; HUMAN; HYPERCHOLESTEROLEMIA; MUSCLE RELAXATION; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; REVIEW; SENESCENCE; THROMBOCYTE; THROMBOCYTE AGGREGATION; TISSUE REGENERATION; VASOSPASM; ANIMAL; METABOLISM; PATHOLOGY; REGENERATION; VASCULAR ENDOTHELIUM; VASOCONSTRICTION;

ANIMALS; BLOOD PLATELETS; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; HUMANS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; PLATELET AGGREGATION; REGENERATION; THROMBIN; VASOCONSTRICTION;

EID: 84961644595     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-16-0179     Document Type: Review

References (66)

1. Vanhoutte PM. The endothelium-modulator of vascular smoothmuscle tone. N Engl J Med 1988; 319: 512-513.
2. Furchgott RF, Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB J 1989; 3: 2007-2017.
3. Vanhoutte PM. Endothelial dysfunction in hypertension. J Hypertens Suppl 1996; 14: S83-S89.
4. Vanhoutte PM. Endothelial dysfunction and atherosclerosis. Eur Heart J 1997; 18: E19-E29.
5. Vanhoutte PM. Ageing and endothelial dysfunction. Eur Heart J 2002; 4: A8-A17.
6. Félétou M, Vanhoutte PM. Endothelial dysfunction: A multifaceted disorder (The Wiggers Award Lecture). Am J Physiol Heart Circ Physiol 2006; 291: 985-1002.
7. Vanhoutte PM. Endothelial dysfunction: The first step toward coronary arteriosclerosis. Circ J 2009; 73: 595-601.
8. Vanhoutte PM. How we learned to say NO. Arterioscler Thromb Vasc Biol 2009a; 29: 1156-1160.
9. Vanhoutte PM, Tang E, Félétou M, Shimokawa H. Endothelial dysfunction and vascular disease. Acta Physiol 2009; 196: 193-222.
10. Vanhoutte PM. Endothelial dysfunction in obesity. Ann Pharm Fr 2013; 71: 42-50.
11. Vanhoutte PM, Tang E, Félétou M, Shimokawa H. Endothelial dysfunction and vascular disease: A 30th anniversary update. Acta Physiol 2016 January 25, doi:10.1111/apha.12646.
12. Félétou M, Vanhoutte PM. EDHF: An update. Clin Sci (Lond) 2009; 117: 139-155.
13. Félétou M, Huang Y, Vanhoutte PM. Endothelium-mediated control of vascular tone: COX-1 and COX-2 products. Br J Pharmacol 2011; 164: 894-912.
14. Vanhoutte PM. Endothelium-dependent contractions in hypertension: When prostacyclin becomes ugly. Hypertension 2011; 57: 526-531.
15. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-376.
16. De Mey JG, Claeys M, Vanhoutte PM. Endothelium-dependent inhibitory effects of acetylcholine, adenosine triphosphate, thrombin and arachidonic acid in the canine femoral artery. J Pharmacol Exp Ther 1982; 222: 166-173.
17. Houston DS, Shepherd JT, Vanhoutte PM. Adenine nucleotides, serotonin, and endothelium-dependent relaxations to platelets. Am J Physiol Heart Circ Physiol 1985; 248: H389-H395.
18. Houston DS, Shepherd JT, Vanhoutte PM. Aggregating human platelets cause direct contraction and endothelium-dependent relaxation of isolated canine coronary arteries: Role of serotonin, thromboxane A2, and adenine nucleotides. J Clin Invest 1986; 78: 539-544.
19. Cohen RA, Shepherd JT, Vanhoutte PM. 5-Hydroxytryptamine can mediate endothelium-dependent relaxation of coronary arteries. Am J Physiol Heart Circ Physiol 1983; 245: H1077-H1080.
20. Cohen RA, Shepherd JT, Vanhoutte PM. Endothelium and asymmetrical responses of the coronary arterial wall. Am J Physiol Heart Circ Physiol 1984; 247: H403-H408.
21. Cohen RA, Shepherd JT, Vanhoutte PM. Inhibitory role of the endothelium in the response of isolated coronary arteries to platelets. Science 1983; 221: 273-274.
22. Cohen RA, Shepherd JT, Vanhoutte PM. Vasodilatation mediated by the coronary endothelium in response to aggregating platelets. Bibl Cardiol 1984; 38: 35-42.
23. Flavahan NA, Shimokawa H, Vanhoutte PM. Pertussis toxin inhibits endothelium-dependent relaxations to certain agonists in porcine coronary arteries. J Physiol 1989; 408: 549-560.
24. Shimokawa H, Flavahan NA, Vanhoutte PM. Natural course of the impairment of endothelium-dependent relaxations after balloon endothelium removal in porcine coronary arteries: Possible dysfunction of a pertussis toxin-sensitive G protein. Circ Res 1989; 65: 740-753.
25. Shimokawa H, Flavahan NA, Vanhoutte PM. Loss of endothelial pertussis toxin-sensitive G-protein function in atherosclerotic porcine coronary arteries. Circulation 1991; 83: 652-660.
26. Flavahan N, Vanhoutte PM. Endothelial cell signaling and endothelial dysfunction. Am J Hypertens 1995; 8: 28S-41S.
27. Boulanger CM, Vanhoutte PM. G-proteins and endothelium-dependent relaxations. J Vasc Res 1997; 34: 175-185.
28. Komori K, Shimokawa H, Vanhoutte PM. Endothelium-dependent relaxations to aggregating platelets in porcine femoral veins and its modulation by diet. Circulation 1989; 80: 401-409.
29. Komori K, Shimokawa H, Vanhoutte PM. Hypercholesterolemia impairs endothelium-dependent relaxations to aggregating platelets in porcine iliac arteries. J Vasc Surg 1989; 10: 318-325.
30. Shimokawa H, Vanhoutte PM. Hypercholesterolemia causes generalized impairment of endothelium-dependent relaxation to aggregating platelets in porcine arteries. J Am Coll Cardiol 1989; 13: 1402-1408.
31. Komori K, Shimokawa H, Vanhoutte PM. Hypercholesterolemia impairs endothelium-dependent relaxations to aggregating platelets in porcine iliac arteries. J Vasc Surg 1989; 10: 318-325.
32. Zellers TM, Shimokawa H, Yunginger J, Vanhoutte PM. Heterogeneity of endothelium-dependent and endothelium-independent responses to aggregating platelets in porcine pulmonary arteries. Circ Res 1991; 68: 1437-1445.
33. Shimokawa H, Lam JY, Chesebro T, Bowie JH, Walter EJ, Vanhoutte PM. Effects of dietary supplementation with cod-liver oilon endothelium-dependent responses in porcine coronary arteries. Circulation 1987; 76: 898-905.
34. Shimokawa H, Vanhoutte PM. Dietary cod-liver oil improves endothelium-dependent responses in hypercholesterolemic and atherosclerotic porcine coronary arteries. Circulation 1988; 78: 1421-1430.
35. Shimokawa H, Kim P, Vanhoutte PM. Endothelium-dependent relaxation to aggregating platelets in isolated basilar arteries of control and hypercholesterolemic pigs. Circ Res 1988; 63: 604-612.
36. Shimokawa H, Vanhoutte PM. Impaired endothelium-dependent relaxation to aggregating platelets and related vasoactive substances in porcine coronary arteries in hypercholesterolemia and in atherosclerosis. Circ Res 1989; 64: 900-914.
37. Kim PM, Shimokawa H, Vanhoutte PM. Dietary ω-3 fatty acids and endothelium-dependent responses in porcine cerebral arteries. Stroke 1992; 3: 407-413.
38. Hibbert B, Olsen S, O’Brien E. Involvement of progenitor cells in vascular repair. Trends Cardiovasc Med 2003; 13: 322-326.
39. Sata M. Circulating vascular progenitor cells contribute to vascular repair, remodeling, and lesion formation. Trends Cardiovasc Med 2003; 13: 249-253.
40. Dimmeler S, Zeiher AM. Vascular repair by circulating endothelial progenitor cells: The missing link in atherosclerosis? J Mol Med 2004; 82: 671-677.
41. Lamping K. Endothelial progenitor cells: Sowing the seeds for vascular repair. Circ Res 2007; 100: 1243-1245.
42. Zampetaki A, Kirton JP, Xu Q. Vascular repair by endothelial progenitor cells. Cardiovas Res 2008; 78: 413-421.
43. Hagensen MK, Vanhoutte PM, Bentzon JF. Arterial endothelial cells: Still the craftsmen of regenerated endothelium. Cardiovasc Re 2012; 95: 281-289.
44. Shimokawa H, Aarhus AA, Vanhoutte PM. Porcine coronary arteries with regenerated endothelium have a reduced endothelium-dependent responsiveness to aggregating platelets and serotonin. Circ Res 1987; 61: 256-270.
45. Shimokawa H, Flavahan NA, Shepherd JT, Vanhoutte PM. Endothelium-dependent inhibition of ergonovine-induced contraction is impaired in porcine coronary arteries with regenerated endothelium. Circulation 1989; 80: 643-650.
46. Shimokawa H, Vanhoutte PM. Angiographic demonstration of hyperconstriction induced by serotonin and aggregating platelets in porcine coronary arteries with regenerated endothelium. J Am Coll Cardiol 1991; 17: 1197-1202.
47. Day NS, Ge T, Codina J, Birnbaumer L, Vanhoutte PM, Boulanger CM. Gi proteins and the response to serotonin in cultured porcine endothelial cells with impaired release of EDRF. Br J Pharmacol 1995; 115: 822-827.
48. Shibano T, Codina J, Birnbaumer L, Vanhoutte PM. Pertussis toxinsensitive G-proteins in regenerated endothelial cells after balloon denudation of porcine coronary artery. Am J Physiol Heart Circ Physiol 1994; 267: H979-H981.
49. Borg-Capra C, Fournet-Bourguignon MP, Janiak P, Villeneuve N, Bidouard JP, Vilaine JP, et al. Morphological heterogeneity with normal expression but altered function of G proteins in porcine cultured regenerated coronary endothelial cells. Br J Pharmacol 1997; 122: 999-1008.
50. Fournet-Bourguignon MP, Castedo-Delrieu M, Bidouard JP, Leonce S, Saboureau D, Delescluse I, et al. Phenotypic and functional changes in regenerated porcine coronary endothelial cells: Increased uptake of modified LDL and reduced production of NO. Circ Res2000; 86: 854-861.
51. Vanhoutte PM, Fournet-Bourguignon MP, Vilaine JP. Dysfonction de la voie du monoxide d’azote au cours de la régénération de l’endothélium coronarien. CR Acad Natl Méd 2002; 186: 1525-1541 (in French).
52. Kennedy S, Fournet-Bourguignon MP, Breugnot C, Castedo-Delrieu M, Lesage L, Reure H, et al. Cells derived from regenerated endothelium of the porcine coronary artery contain more oxidized forms of Apolipoprotein-B-100 without a modification in the uptake of oxidized LDL. J Vasc Res 2003; 40: 389-398.
53. Lee MYK, Tse HF, Siu CW, Zhu SG, Man RYK, Vanhoutte PM. Genomic changes in regenerated porcine coronary arterial endothelial cells. Arterioscler Thromb Vasc Biol 2007; 27: 2443-2449.
54. Boulanger C, Bühler FR, Lüscher TF. Low density lipoproteins impair the release of endothelium-derived relaxing factor from cultured porcine endothelial cells (abstract). Eur Heart J 1985; 10: 331.
55. Cox DA, Cohen ML. Selective enhancement of 5-hydroxytryptamine-induced contraction of porcine coronary artery by oxidized low-density lipoprotein. J Pharmacol Exp Ther 1996; 276: 1095-1103.
56. Lee MYK, Wang Y, Vanhoutte P. Senescence of cultured porcine coronary arterial endothelial cells is associated with accelerated oxidative stress and activation of NFκB. J Vasc Res 2010; 47: 287-298.
57. Lee M, Li H, Xiao Y, Zhou Z, Xu A, Vanhoutte PM. Chronic administration of BMS309403, an inhibitor of adipocyte fatty acid-binding protein (A-FABP) improves endothelial function in apolipoprotein E-deficient (ApoE–/–) mice and in cultural human endothelial cells. Br J Pharm 2011; 162: 1564-1576.
58. Furuhashi M, Tuncman G, Gorgun CZ, Makowski L, Atsumi G, Vaillancourt E, et al. Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2. Nature 2007; 447: 959-965.
59. Chan C, Zhao Y, Liao SY, Zhang YL, Lee M, Xu A, et al. A-FABP and oxidative stress underlie the impairment of endothelium-dependent relaxations to serotonin and the intima-medial thickening in the porcine coronary artery with regenerated endothelium. ACS Chem Neurosci 2013; 4: 122-129.
60. Vanhoutte PM. MMP-7 and cardiovascular disease: Not so surprising! Basic Clin Pharmacol Technol 2013; 112: 2.
61. Perrault LP, Bidouard JP, Janiak P, Villeneuve N, Bruneval P, Vilaine JP, et al. Time course of coronary endothelial dysfunction in acute untreated rejection after heterotopic heart transplantation. J Heart Lung Transplant 1997; 16: 643-657.
62. Perrault LP, Bidouard JP, Janiak P, Villeneuve N, Bruneval P, Vilaine JP, et al. Impairment of G-protein-mediated signal transduction in the porcine coronary endothelium during rejection after heart transplantation. Cardiovasc Res 1999; 43: 457-470.
63. Perrault LP, Malo O, Bidouard J, Villeneuve N, Vilaine J, Vanhoutte PM. Inhibiting the NO pathway wit intracoronary L-NAME infusion increases endothelial dysfunction and intimal hyperplasia after heart transplantation. J Heart Lung Transplant 2003; 22: 439-451.
64. Ross R. Atherosclerosis: An inflammatory disease. N Engl J Med 1999; 340: 115-126.
65. Aikawa M, Libby P. The vulnerable atherosclerotic plaque Pathogenesis and therapeutic approach. Cardiovasc Pathol 2004; 13: 125-138.
66. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685-1695.